Searle & Co. Horizon Therapeutics Public LTD CO Transaction History

Searle & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $86,127 - $100,467	-894 Reduced 4.02%	21,350 $2.2 Million
Q1 2023 Jun 01, 2023	SELL	$107.32 - $113.5 $118,695 - $125,531	-1,106 Reduced 4.74%	22,244 $2.43 Million
Q3 2022 Oct 26, 2022	SELL	$58.92 - $84.67 $8,838 - $12,700	-150 Reduced 0.64%	23,350 $1.45 Million
Q2 2022 Aug 03, 2022	BUY	$79.4 - $116.36 $79,400 - $116,360	1,000 Added 4.44%	23,500 $1.87 Million
Q1 2021 May 12, 2021	SELL	$71.83 - $95.48 $53,872 - $71,610	-750 Reduced 3.23%	22,500 $2.07 Million
Q4 2020 Feb 04, 2021	BUY	$67.0 - $84.39 $703,500 - $886,095	10,500 Added 82.35%	23,250 $1.7 Million
Q1 2020 May 12, 2020	BUY	$24.87 - $38.56 $317,092 - $491,640	12,750 New	12,750 $378,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.